Focused On-demand Library for Cytochrome c oxidase copper chaperone

Focused On-demand Libraries - Receptor.AI Collaboration


Explore the Potential with AI-Driven Innovation

The focused library is created on demand with the latest virtual screening and parameter assessment technology, supported by the Receptor.AI drug discovery platform. This method is more effective than traditional methods and results in higher-quality compounds with better activity, selectivity, and safety.


The compounds are cherry-picked from the vast virtual chemical space of over 60B molecules. The synthesis and delivery of compounds is facilitated by Reaxense.


The library includes a list of the most effective modulators, each annotated with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Furthermore, each compound is shown with its optimal docking poses, affinity scores, and activity scores, offering a detailed summary.


We use our state-of-the-art dedicated workflow for designing focused libraries.


 

Fig. 1. The screening workflow of Receptor.AI

Our methodology leverages molecular simulations to examine a vast array of proteins, capturing their dynamics in both isolated forms and in complexes with other proteins. Through ensemble virtual screening, we thoroughly account for the protein's conformational mobility, identifying critical binding sites within functional regions and distant allosteric locations. This detailed exploration ensures that we comprehensively assess every possible mechanism of action, with the objective of identifying novel therapeutic targets and lead compounds that span a wide spectrum of biological functions.


Our library stands out due to several important features:


  • The Receptor.AI platform compiles comprehensive data on the target protein, encompassing previous experiments, literature, known ligands, structural details, and more, leading to a higher chance of selecting the most relevant compounds.

  • Advanced molecular simulations on the platform help pinpoint potential binding sites, making the compounds in our focused library ideal for finding allosteric inhibitors and targeting cryptic pockets.

  • Receptor.AI boasts over 50 tailor-made AI models, rigorously tested and proven in various drug discovery projects and research initiatives. They are crafted for efficacy, dependability, and precision, all of which are key in creating our focused libraries.

  • Beyond creating focused libraries, Receptor.AI offers comprehensive services and complete solutions throughout the preclinical drug discovery phase. Our success-based pricing model minimises risk and maximises the mutual benefits of the project's success.

PARTNER
Receptor.AI
 
UPACC
Q14061

UPID:
COX17_HUMAN

ALTERNATIVE NAMES:
-

ALTERNATIVE UPACC:
Q14061; B2R5D2; D3DN84; Q3MHD6

BACKGROUND:
Cytochrome c oxidase copper chaperone is crucial for mitochondrial health, serving as a copper metallochaperone for the assembly of complex IV of the respiratory chain. It ensures the delivery of copper ions to SCO1, which in turn transports them to the Cu(A) site on the cytochrome c oxidase subunit, facilitating efficient electron transport and ATP production.

THERAPEUTIC SIGNIFICANCE:
Exploring the Cytochrome c oxidase copper chaperone's function offers a promising pathway to novel treatments. By targeting this protein, researchers may develop interventions to correct mitochondrial dysfunctions, potentially offering relief for conditions stemming from compromised energy production.

Looking for more information on this library or underlying technology? Fill out the form below and we will be in touch with all the details you need.


Page 7374 of 8789